Haleon plc Profile Avatar - Palmy Investing

Haleon plc

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain r…
Drug Manufacturers - Specialty & Generic
GB, Weybridge [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 67% Positive
Leverage & Liquidity n.A. n.A.
Per Share Metrics 67% Positive
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA -66.44 46.67 139.05
Graham Fair Price 1261.90 2.74 0.20
PEG -100.00 < 0.005 28.12
Price/Book -10.81 1.83 2.05
Price/Cash Flow 0.00 0.00 0.00
Prices/Earnings -99.36 18.05 -2833.30
Price/Sales -14.86 10.47 12.29
Price/FCF 0.00 0.00 0.00
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin 17.60 0.63 0.54
Operating Margin 131.48 0.23 0.10
ROA inf 0.00 < 0.005
ROE < 0.005 0.03 13896.33
ROIC < 0.005 0.03 6889.46
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ -1.00 0.00 -100.00
Dividends QOQ 0.00 0.00 0.00
EBIT QOQ -0.54 1.44 169.20
EPS QOQ -1.01 7667.67 760894.27
FCF QOQ 0.00 0.00 0.00
Revenue QOQ -0.01 0.06 383.66
Naive Interpretation member
03 - Financial Growth · Positive
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 98.61 0.00 inf
Days Sales Outstanding (DSO) 43.99 0.00 inf
Inventory Turnover 0.91 0.00 inf
Debt/Capitalization 0.36 0.00 inf
Quick Ratio 0.52 0.00 inf
Naive Interpretation member
04 - Leverage & Liquidity · Not Interpreted
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 3.16 3.64 15.12
Cash 0.20 0.23 14.27
Capex 0.00 0.00 0.00
Free Cash Flow 0.00 0.00 0.00
Revenue 0.53 0.63 20.59
Naive Interpretation member
05 - Per Share Metrics · Positive
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 1.04 0.00 inf
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 27.58 1.54 -94.41
Naive Interpretation Member
06 - Financial Health · Bad
End of HLN's Analysis
CIK: 1900304 CUSIP: 405552100 ISIN: US4055521003 LEI: - UEI: -
Secondary Listings